National Health Investors Up 8.97% Quarterly, EPS Forecast Raised to $4.90
National Health Investors shares gained 8.97% over the past quarter and 2.37% in the last week, surpassing its REIT industry’s 2.67% weekly rise. Analysts have raised 2026 EPS forecasts from $4.84 to $4.90 and anticipate Q4 EPS of $1.23 on $95.6 million revenue, due Feb. 26.
1. Strong Price Momentum
National Health Investors shares rose 2.37% last week, outpacing its REIT peer group’s 2.67% gain, and climbed 8.65% over the past month. Over the last quarter and year, shares gained 8.97% and 24.42%, respectively, versus the S&P 500’s 3.37% annual advance, on a 20-day average volume of 211,015.
2. Earnings Estimate Revisions and Q4 Outlook
Full-year EPS forecasts have increased from $4.84 to $4.90 over the past 60 days, driven by two upward revisions and no downward moves. The company is projected to report Q4 EPS of $1.23, up 8.9% year-over-year, on $95.6 million revenue when results are released Feb. 26.